Transcriptional output in a prospective design conditionally on follow-up and exposure: The multistage model of cancer

International Journal of Molecular Epidemiology and Genetics

Volumn 3, Issue 2, 2012, Pages 107-114

  Lund, Eiliv ^a   Plancade, Sandra ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Carcinogenesis; Latent variable; Multistage model; Prospective study; Systems epidemiology; Transcriptomics

Indexed keywords

CARCINOGEN;

CANCER EPIDEMIOLOGY; CANCER MODEL; CANCER STAGING; CARCINOGENESIS; FOLLOW UP; GENE EXPRESSION; HUMAN; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TRANSCRIPTOMICS;

EID: 84861764235     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358: 502-511.
2. Farazi TA, Spitzer JI, Morozow P, Tuschl T. Mirna in human cancer. J Pathol 2011; 223; 102-115.
3. Dumeaux V, Børresen-Dale AL, Frantzen JO, Kumle M, Kristensen VN, Lund E. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study. Breast Cancer Res 2008; 10: R13.
4. Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Molecular Cancer 2010; 9; 306.
5. Freedman ML, Monteiro AN, Gayther SA, Coet-zee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, Mills IG. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics 2011; 43; 513-518.
6. Lund E, Dumeaux V. Systems epidemiology. CEBP 2008; 17: 2954-2957.
7. Lund E, Dumeaux V, Braaten T, Hjartåker J, Enge-set D, Skeie G, Kumle M. Cohort profile: The Norwegian women and cancer study - NOWAC -Kvinner og kreft. International Journal of Epidemiology 2008; 37: 36-41.
8. Spitz MR, Bondy ML. The evolving discipline of molecular epidemiology of cancer. Carcino-genesis 2010; 31; 127-134.
9. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformat-ics 2003; 19; 368-375.
10. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
11. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009; 458: 719-724.
12. Vineis P, Schatzkin A, Potter JD. Models of car-cinogenesis: An overview. Carcinogenesis 2010; 31: 1703-1709.
13. Armitage P. Multistage models of carcinogenesis. Env Health Perspective 1985; 63: 195-201.
14. Cox LA, Huber WA. Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcino-genesis. Risk Analysis 2007; 6: 1441-1453.
15. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954; 8: 1-12.
16. Moolgavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. JNCI 1980; 65: 559-569.
17. Day NE, Brown CC. Multistage models and primary prevention of cancer. J Natl Cancer Inst 1980; 64: 977-989.
18. Lund E, Dumeaux V. Towards a more functional concept of causality in cancer research. Int J Mol Epidemiol Genet 2010; 1: 124-133.
19. Imaoka T, Nishimura M, Iizuka D, Daino K, Takabatake T, Okamoto M, Kakinuma S, Shimida Y. Radiation-induced mammary car-cinogenesis in rodent models: What's different from chemical carcinogenesis? J Radiat Res 2009; 50: 281-293.
20. Lizano M, Berumen J, Garcia-Carranca A. HPV-related carcinogenesis: Basic concepts, viral types and variants. Arch Med Res 2009; 40: 428-434.
21. Hernandez LG, van Steeg H, Luitjen M, van Benthem J. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mut Res 2009; 682: 94-109.
22. Vineis P, Chadeau-Hyam M. Integrating bio-markers into molecular epidemiological studies. Curr Opin Oncol 2011; 23: 100-105.
23. Dumeaux V, Olsen SK, Paulssen RH, Børresen-Dale AL, Lund E. Deciphering blood gene expression variation - The postgenome NOWAC study. PLoS Genetics 2010; 6: e1000873.
24. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H, D'Asaro M, Chiappe A, Sridhar S, Pacheco GD, Burczynski ME, Hochstrasser D, Vonderscher J, Matthes T. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. Plos ONE 2012; 7: e29979.
25. Birnbaum KD, Kussell E. Measuring cell identity in noisy biological systems. Nucl Acids res 2011; 39: 9037-9107.
26. Potter JD. Epidemiology informing clinical practice: from bills of mortality to population laboratories. Nat Clin Pract Oncol 2005; 2: 625-634.
27. Baker SG, Cappuccio A, Potter JD. Research on early-stage carcinogenesis: Are we approaching paradigm instability? J Clin Onc 2010; 28: 3215-3218.
28. Weinstein B, Joe A. Oncogene addiction. Cancer Res 2008; 68: 3077-3080.
29. Felsher DW. Oncogene addiction versus onco-gene amnesia: Perhaps more than just a bad habit. Cancer Res 2008; 68: 3081-3086.